www.fdanews.com/articles/192550-cordis-vascular-closure-device-receives-ce-mark
Cordis’ Vascular Closure Device Receives CE Mark
August 29, 2019
Cordis has obtained the CE Mark for its Mynx Control vascular closure device (VCD), a product used in patients who have undergone diagnostic or interventional vascular procedures.
The device is designed to achieve hemostasis and ambulation in patients at a faster rate, using active extravascular sealing and full resorbability into a new delivery system to close femoral arterial access sites.
The system automates multiple procedure steps and provides visual confirmation of the device’s positioning for proper sealant deployment.